FTC highlights new concern over 'pay-to-delay' deals that determine when generics are sold
March 18, 2025
March 18, 2025
NEW YORK, March 18 [Category: BizLaw/Legal] -- White and Case, a law firm, issued the following news release:
* * *
FTC highlights new concern over 'pay-to-delay' deals that determine when generics are sold
White & Case Antitrust partner Kevin Adam spoke to STAT about the FTC's recent report on patent settlements between brand-name and generic drug makers, specifically regarding whether so-called "quantity restrictions" could be . . .
* * *
FTC highlights new concern over 'pay-to-delay' deals that determine when generics are sold
White & Case Antitrust partner Kevin Adam spoke to STAT about the FTC's recent report on patent settlements between brand-name and generic drug makers, specifically regarding whether so-called "quantity restrictions" could be . . .